FLORINEF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Florinef, and what generic alternatives are available?
Florinef is a drug marketed by Casper Pharma Llc and is included in one NDA.
The generic ingredient in FLORINEF is fludrocortisone acetate. There are four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fludrocortisone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Florinef
A generic version of FLORINEF was approved as fludrocortisone acetate by IMPAX LABS on March 18th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLORINEF?
- What are the global sales for FLORINEF?
- What is Average Wholesale Price for FLORINEF?
Summary for FLORINEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Clinical Trials: | 7 |
| DailyMed Link: | FLORINEF at DailyMed |
Recent Clinical Trials for FLORINEF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ahvaz Jundishapur University of Medical Sciences | Phase 3 |
| Urmia University of Medical Sciences | Phase 3 |
| Rajaie Cardiovascular Medical and Research Center | Phase 3 |
US Patents and Regulatory Information for FLORINEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casper Pharma Llc | FLORINEF | fludrocortisone acetate | TABLET;ORAL | 010060-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
